Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07012291 · ClinicalTrials.gov registry record
Clinical Performance Evaluation of Native Whole Blood Samples of Patients on DOACs With the Perosphere ClotChek™
A clinical trial of Coagulation, sponsored by Perosphere Technologies.
- Recruiting
- Registry status
- 150
- Enrollment target
- 4
- Study locations
NCT07012291: Recruiting study of Coagulation, sponsored by Perosphere Technologies.
NCT07012291 is a study of Coagulation that is actively recruiting participants, run by Perosphere Technologies. The registered enrollment target is 150 participants. The trial reports 4 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07012291, a study of Coagulation, is actively recruiting participants, sponsored by Perosphere Technologies.
- RECRUITING
- Registry status
- 150 participants
- Enrollment target
- 4
- Study locations
Study Summary
The Perosphere ClotChek™ system consists of a hand-held, battery-operated blood coagulation instrument and disposable test cuvettes for use at the point-of-care (POC). The instrument performs a whole blood clotting time (WBCT) test using freshly drawn, non-citrated whole blood. The purpose of the present study is to characterize the performance of the Perosphere ClotChek™ as a quantitative measurement of the WBCT in patients taking one of the following Direct Oral Anticoagulants (DOACs), rivaroxaban or apixaban.
Conditions Studied
Interventions
- DEVICE Whole Blood Clotting Time
Study Locations (4)
Connecticut
- Perosphere Technologies Inc - Danbury
Maryland
- Perosphere Technologies Inc - Rockville
New Jersey
- Eastern Vascular Associates - Denville
New York
- Bassett Research Institute - Center for Clinical Research - Cooperstown
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2025-06-20 |
| Est. Completion | 2027-06-01 |
What NCT07012291 shows while recruiting
NCT07012291 is an observational study that tracks outcomes without assigning an intervention. The registered 150 participants enrollment target is mid-sized for trials with a published cap.
The record links to 1 condition, with Coagulation appearing as the primary indexed condition, and to 1 intervention - of which Whole Blood Clotting Time is the first listed.
NCT07012291 reports a single indexed study location in Connecticut, Maryland, New Jersey.
Frequently Asked Questions
What is clinical trial NCT07012291 about?
NCT07012291 is a clinical study titled "Clinical Performance Evaluation of Native Whole Blood Samples of Patients on DOACs With the Perosphere ClotChek™". The Perosphere ClotChek™ system consists of a hand-held, battery-operated blood coagulation instrument and disposable test cuvettes for use at the point-of-care (POC). The instrument performs a whole blood clotting time (WBCT) test using freshly drawn, non-citrated whole blood. The purpose of the pr...
What is the current status of trial NCT07012291?
This trial is currently recruiting. The enrollment target is 150 participants. The study started on 2025-06-20. Estimated completion is 2027-06-01.
What conditions does trial NCT07012291 study?
This clinical trial studies the following conditions: Coagulation.
What interventions are being tested in trial NCT07012291?
The interventions under investigation include: Whole Blood Clotting Time (DEVICE).
Who is sponsoring clinical trial NCT07012291?
This trial is sponsored by Perosphere Technologies, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07012291 being conducted?
This trial has 4 study locations across Connecticut, Maryland, New Jersey, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Coagulation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00412594 · 150 participants · Phase 2
Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia
- NCT01484730 · 150 participants
A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion
- NCT01985919 · 150 participants
Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples
- NCT02016248 · 150 participants · NA
SBRT Boost for Unfavorable Prostate Cancer'
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI